The value of interleukin-1 beta (IL-1β) measurement in the detection of bacterial urinary tract infection in symptomatic and asymptomatic bacteriuria patients
The Egyptian journal of Immunology · 01.04.2026 · 33 (2) · 76-85
DOI: 10.55133/eji.330207 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian journal of Immunology, online erschienen am 01.04.2026. Verfasst von Mariam E E Sarhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, Damietta Faculty of Medicine (Girls), Al-Azhar University, Egypt. Hauptthemen laut MEDLINE: Interleukin-1beta, Urinary Tract Infections, Bacteriuria, Escherichia coli Infections.
Abstract (Originalsprache)
Urinary tract infections (UTIs) are common bacterial infections that trigger inflammatory responses, while asymptomatic bacteriuria involves bacterial presence without symptoms. Diagnosing UTIs can be challenging and delays may lead to complications or antibiotic misuse. Interleukin-1 beta (IL-1β), an early proinflammatory cytokine detected in urine, shows potential as a rapid UTIs diagnostic biomarker. This study aimed to investigate urinary IL-1β levels in patients with symptomatic UTIs, asymptomatic bacteriuria, and normal control individuals. We compared IL-1β levels between subjects with multidrug-resistant (MDR), and others with drug-sensitive bacterial infections. This study included 150 subjects who were categorized into three groups: symptomatic UTIs, asymptomatic bacteriuria, and normal controls. Urine samples were collected aseptically and analyzed using Cystine Lactose Electrolyte Deficient (CLED) agar culture and antimicrobial susceptibility testing (disc diffusion method). Urinary IL-1β levels were measured using ELISA. Escherichia coli was the most commonly isolated organism, followed by Klebsiella pneumoniae. Cefotaxime, amikacin, and cefixime showed good sensitivity, with cefixime being significantly more effective in asymptomatic bacteriuria. IL-1β levels were markedly higher in symptomatic UTI patients, followed by asymptomatic bacteriuria, and lowest in the controls. The highest IL-1β levels were associated with E. coli infections and MDR strains. In conclusion, urinary IL-1β represents a promising biomarker for UTI diagnosis, capable of distinguishing between UTI cases and normal controls and correlating with bacterial resistance patterns. These findings support the incorporation of IL-1β measurement into clinical practice to enhance diagnostic accuracy and improve infection management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, Damietta Faculty of Medicine (Girls), Al-Azhar University, Egypt.
- Department of Medical Microbiology and Immunology, Damietta Faculty of Medicine, Al-Azhar University, Egypt.
- Department of Medical Microbiology and Immunology, Faculty of Medicine for Girls (Cairo), Al-Azhar University, Egypt.
- Department of Clinical Pathology, Damietta Faculty of Medicine, Al-Azhar University, Egypt.
Zitieren
APA
Sarhan, M. E. E., Abd Eltwab, R. A., Elgamal, S. A., & Alkhrsawy, A. M. A. (2026). The value of interleukin-1 beta (IL-1β) measurement in the detection of bacterial urinary tract infection in symptomatic and asymptomatic bacteriuria patients. The Egyptian journal of Immunology, 33(2), 76-85. https://doi.org/10.55133/eji.330207
Vancouver
Sarhan MEE, Abd Eltwab RA, Elgamal SA, Alkhrsawy AMA. The value of interleukin-1 beta (IL-1β) measurement in the detection of bacterial urinary tract infection in symptomatic and asymptomatic bacteriuria patients. The Egyptian journal of Immunology. 2026;33(2):76-85. doi:10.55133/eji.330207
BibTeX
@article{Sarhan2026,
author = {Sarhan, Mariam E E and Abd Eltwab, Raafat A and Elgamal, Safia A and Alkhrsawy, Amr M A},
title = {The value of interleukin-1 beta (IL-1β) measurement in the detection of bacterial urinary tract infection in symptomatic and asymptomatic bacteriuria patients},
journal = {The Egyptian journal of Immunology},
year = {2026},
volume = {33},
number = {2},
pages = {76--85},
doi = {10.55133/eji.330207}
}
EUVIMED